Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lung Neoplasms 6Breast Neoplasms 6Uterine Cervical Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 2Lymphoma, B-Cell, Marginal Zone 2Liver Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Precancerous Conditions 1Pleural Effusion, Malignant 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Mycosis Fungoides 1Meningioma 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1

Interventions

ixabepilone 2aldesleukin 2Oxaliplatin 2sargramostim 1rF-B7.1 vaccine 1peginterferon alfa-2b 1indolepropanol phosphate 1fludarabine phosphate 1birinapant 1becatecarin 1alvocidib 1Topotecan 1Sorafenib 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1O(6)-benzylguanine 1Nitroarginine 1Methods 1Magnetic Resonance Spectroscopy 1Lapatinib 1Interleukin-2 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gemcitabine 1Fluorodeoxyglucose F18 1Filgrastim 1Early Intervention, Educational 1Docetaxel 1Decitabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Unspecified Adult Solid Tumor, Protocol Specific × Fluorodeoxyglucose F18 × Clear all
NCT02070406 2019-02-28

Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies

Jonsson Comprehensive Cancer Center

Phase 1 Terminated
4 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡